Page last updated: 2024-08-21

oxazoles and Bacterial Skin Diseases

oxazoles has been researched along with Bacterial Skin Diseases in 36 studies

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's32 (88.89)24.3611
2020's4 (11.11)2.80

Authors

AuthorsStudies
Calabuig Muñoz, E; Castells Lao, G; Isernia, V; López Suñé, E; Mensa Pueyo, J; Mensa Vendrell, M; Morata Ruiz, L; Moreno Nuñez, L; Oltra Sempere, MR; Pasquau Liaño, J; Pedro-Botet Montoya, ML; Reynaga Sosa, EA; Salavert Lletí, M; Sequera Arquelladas, S; Soriano Viladomiu, A; Tasias Pitarch, M; Yuste Ara, JR1
Atlihan-Gundogdu, E; Demir, ES; Karpuz, M; Senyigit, Z1
Broyde, N; Butterton, JR; Croce, M; De Anda, C; Fujimi, S; Kim, JY; Popejoy, MW; Rodriguez Gonzalez, D; Roquilly, A; Wunderink, RG1
Kase, M; Kitaoka, A; Kobayashi, S; Matsubara, M; Yasu, T1
Anuskiewicz, S; De Anda, C; Prokocimer, P; Vazquez, J1
Anuskiewicz, S; Bidell, M; De Anda, C; Flanagan, S; Hardalo, C; Lodise, TP; Prokocimer, P1
Iwamoto, Y; Kato, M; Kohno, S; Mikamo, H; Takesue, Y; Tanigawa, T; Tanimura, Y1
Alder, J; Li, L; Lv, X; O'Riordan, W; Rybak, MJ; Wilcox, MH; Ye, H; Zhang, R; Zhang, Z; Zhu, X1
Das, A; De Anda, C; Fang, E; Mehra, P; Prokocimer, P1
Boucher, HW; Doron, S1
Espona, M; Ferrández, I; Ferrández, O; Grau, S; Salas, E; Urbina, O1
Spellberg, B1
Das, A; Prokocimer, P1
Bien, P; De Anda, C; Prokocimer, P1
Corey, GR; Das, AF; De Anda, C; Fang, E; Moran, GJ; Prokocimer, P1
Kern, WV; Tacconelli, E1
Fiedler-Kelly, J; Flanagan, S; Lu, Q; Ludwig, E; Passarell, J; Prokocimer, P1
Gras, J1
Adam, H; Gilmour, M; Gin, AS; Golden, A; Gorityala, B; Hoban, DJ; Karlowsky, JA; Lagacé-Wiens, PR; Love, R; Lynch, JP; Rubinstein, E; Schweizer, F; Walkty, A; Zelenitsky, S; Zhanel, GG1
Drekonja, DM1
Taylor, J1
Corey, GR; Das, AF; Moran, GJ; Prokocimer, P1
Burdette, SD; Trotman, R1
Chahine, EB; Knutsen, SD; Sucher, AJ1
Hui, Y; Xiaoju, L1
Bassetti, M; Concia, E; Cristini, F; De Rosa, FG; Esposito, S; Menichetti, F; Petrosillo, N; Russo, A; Tumbarello, M; Venditti, M; Viale, P; Viscoli, C1
Li, R; Nailor, MD1
Das, AF; De Anda, C; Powers, JH; Prokocimer, P1
Cao, B; Chen, H; Chu, Y; Du, Y; Feng, X; Fu, Q; Gui, Q; Guo, Y; Hu, B; Hu, Y; Hu, Z; Ji, P; Jia, W; Jin, Y; Lei, JE; Li, S; Liao, K; Liu, Z; Ni, Y; Wang, H; Wang, Z; Xu, X; Yang, Q; Yu, Y; Zeng, J; Zhang, R; Zhang, Z; Zhao, C; Zhuo, C1
Corey, R; Das, AF; De Anda, C; Nathwani, D; Prokocimer, P; Sandison, T1
Arber, M; Barata, T; Eales, J; Fleetwood, K; Glanville, J; Gould, IM; Kauf, TL; McCool, R1
Durkin, MJ; Hsueh, K; Krekel, T; McBride, D1
Bridgeman, MB; Dalal, KS1
Das, AF; De Anda, C; Fang, E; Prokocimer, P; Sandison, T1
Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J1

Reviews

11 review(s) available for oxazoles and Bacterial Skin Diseases

ArticleYear
Clinical safety and tolerability of tedizolid phosphate in the treatment of acute bacterial skin and skin structure infections.
    Expert opinion on drug safety, 2018, Volume: 17, Issue:4

    Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Linezolid; Organophosphates; Oxazoles; Severity of Illness Index; Skin Diseases, Bacterial

2018
Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.
    Drug design, development and therapy, 2013, Volume: 7

    Topics: Acute Disease; Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Gram-Positive Bacteria; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Soft Tissue Infections; Tissue Distribution

2013
Two new drugs for skin and skin structure infections.
    The Medical letter on drugs and therapeutics, 2014, Aug-18, Volume: 56, Issue:1449

    Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Infections; Teicoplanin

2014
Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections.
    Drugs of today (Barcelona, Spain : 1998), 2014, Volume: 50, Issue:11

    Topics: Acute Disease; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Bacterial; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial

2014
Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Drugs, 2015, Volume: 75, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Structure; Organophosphates; Oxazoles; Skin Diseases, Bacterial

2015
Tedizolid: The First Once-Daily Oxazolidinone Class Antibiotic.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-15, Volume: 61, Issue:8

    Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Drug Interactions; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Skin Infections

2015
Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections.
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2015, Volume: 30, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Drug Interactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Soft Tissue Infections

2015
Tedizolid for treatment of acute bacterial skin and skin structure infections.
    Expert review of anti-infective therapy, 2015, Volume: 13, Issue:9

    Topics: Acute Disease; Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Treatment Outcome

2015
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22 Suppl 2

    Topics: Ambulatory Care; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; United States; United States Food and Drug Administration

2016
Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA.
    BMC infectious diseases, 2017, 01-07, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Bayes Theorem; Ceftaroline; Cephalosporins; Daptomycin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin

2017
Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.
    Expert opinion on drug metabolism & toxicology, 2017, Volume: 13, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Interactions; Half-Life; Humans; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Soft Tissue Infections

2017

Trials

10 trial(s) available for oxazoles and Bacterial Skin Diseases

ArticleYear
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 08-02, Volume: 73, Issue:3

    Topics: Anti-Bacterial Agents; Double-Blind Method; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Pneumonia, Bacterial; Skin Diseases, Bacterial; Ventilators, Mechanical

2021
Outpatient treatment of acute bacterial skin and skin structure infections (ABSSSI) with tedizolid phosphate and linezolid in patients in the United States: Subgroup analysis of 2 randomized phase 3 trials.
    Medicine, 2017, Volume: 96, Issue:52

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Middle Aged; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Treatment Outcome; United States; Young Adult

2017
Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - Results of a randomised, multicentre phase 3 study.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Humans; Japan; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome

2018
Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Double-Blind Method; Female; Humans; Male; Middle Aged; Organophosphates; Oxazoles; Skin; Skin Diseases, Bacterial; Young Adult

2019
Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.
    JAMA, 2013, Feb-13, Volume: 309, Issue:6

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Treatment Outcome; Young Adult

2013
Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study.
    Surgical infections, 2014, Volume: 15, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Erythema; Humans; Image Interpretation, Computer-Assisted; Linezolid; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; United States

2014
Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:8

    Topics: Acetamides; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome; Young Adult

2014
Clinician-reported lesion measurements in skin infection trials: Definitions, reliability, and association with patient-reported pain.
    Contemporary clinical trials, 2016, Volume: 50

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Organophosphates; Oxazoles; Pain; Reproducibility of Results; Research Design; Skin Diseases, Bacterial; Wounds and Injuries; Young Adult

2016
Clinical Response of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections by Severity Measure Using a Pooled Analysis from Two Phase 3 Double-Blind Trials.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:5

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Double-Blind Method; Humans; Linezolid; Organophosphates; Oxazoles; Skin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Young Adult

2017
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult

2011

Other Studies

15 other study(ies) available for oxazoles and Bacterial Skin Diseases

ArticleYear
Safety and Tolerability of More than Six Days of Tedizolid Treatment.
    Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7

    Topics: Anti-Bacterial Agents; Humans; Organophosphates; Oxazoles; Oxazolidinones; Retrospective Studies; Skin Diseases, Bacterial; Tetrazoles

2020
Radiolabeled Tedizolid Phosphate Liposomes for Topical Application: Design, Characterization, and Evaluation of Cellular Binding Capacity.
    AAPS PharmSciTech, 2021, Feb-02, Volume: 22, Issue:2

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Liposomes; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Technetium

2021
Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: A case report.
    International journal of clinical pharmacology and therapeutics, 2021, Volume: 59, Issue:9

    Topics: Anti-Bacterial Agents; Humans; Linezolid; Microbial Sensitivity Tests; Neutropenia; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Tetrazoles

2021
Antibiotics for skin infections: new study design and a step toward shorter course therapy.
    JAMA, 2013, Feb-13, Volume: 309, Issue:6

    Topics: Anti-Infective Agents; Female; Humans; Male; Organophosphates; Oxazoles; Skin Diseases, Bacterial

2013
End points in trials of treatments for skin infections.
    JAMA, 2013, May-22, Volume: 309, Issue:20

    Topics: Anti-Infective Agents; Female; Humans; Male; Organophosphates; Oxazoles; Skin Diseases, Bacterial

2013
End points in trials of treatments for skin infections--reply.
    JAMA, 2013, May-22, Volume: 309, Issue:20

    Topics: Anti-Infective Agents; Female; Humans; Male; Organophosphates; Oxazoles; Skin Diseases, Bacterial

2013
New antibiotics for skin and skin-structure infections.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:8

    Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial

2014
Tedizolid population pharmacokinetics, exposure response, and target attainment.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Organophosphates; Oxazoles; Oxazolidinones; Platelet Count; Prodrugs; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Young Adult

2014
A closer inspection of tedizolid.
    The Lancet. Infectious diseases, 2015, Volume: 15, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial

2015
A closer inspection of tedizolid.
    The Lancet. Infectious diseases, 2015, Volume: 15, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial

2015
A closer inspection of tedizolid - authors' reply.
    The Lancet. Infectious diseases, 2015, Volume: 15, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Female; Humans; Male; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial

2015
New Gram Positive Agents to Treat Acute Bacterial Skin and Skin Structure Infections.
    Connecticut medicine, 2016, Volume: 80, Issue:3

    Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Costs and Cost Analysis; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Practice Guidelines as Topic; Skin Diseases, Bacterial; Teicoplanin; Treatment Outcome

2016
In vitro activities of tedizolid compared with other antibiotics against Gram-positive pathogens associated with hospital-acquired pneumonia, skin and soft tissue infection and bloodstream infection collected from 26 hospitals in China.
    Journal of medical microbiology, 2016, Volume: 65, Issue:10

    Topics: Anti-Bacterial Agents; China; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Organophosphates; Oxazoles; Pneumonia, Bacterial; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections

2016
Early Clinical Response as a Predictor of Late Treatment Success in Patients With Acute Bacterial Skin and Skin Structure Infections: Retrospective Analysis of 2 Randomized Controlled Trials.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jan-15, Volume: 64, Issue:2

    Topics: Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Humans; Linezolid; Models, Statistical; Organophosphates; Oxazoles; Randomized Controlled Trials as Topic; Retrospective Studies; Sensitivity and Specificity; Skin Diseases, Bacterial; Time Factors; Treatment Outcome

2017
Antibiotics.
    Nursing, 2017, Volume: 47, Issue:3

    Topics: Acute Disease; Anti-Bacterial Agents; Glycopeptides; Humans; Lipoglycopeptides; Organophosphates; Oxazoles; Skin Diseases, Bacterial; Teicoplanin

2017
chemdatabank.com